A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Clinical trial NCT07775924 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07775924
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-10
- Primary completion
- 2028-11-22
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.